Keywords: GlaxoSmithKline, Avandia, Damages settlement, FDA hearings

GlaxoSmithKline reportedly agrees $460 million damages settlement over diabetes drug Avandia, as FDA hearings kick off

Article | 14 July 2010

Print This

UK drugs giant GlaxoSmithKline has agreed to pay about $460 million to resolve a majority of law suits alleging the company’ ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in